source
- Daiichi Sankyo postpones annual results, stock dipsDaiichi Sankyo has pushed back the reporting of its annual results, saying it needs more time to finalize the numbers. The Japanese company had intended to unveil its financials for its fiscal year…Endpoints · 3mo ago↗ source
- FDA approves Regeneron's hearing loss gene therapy OtarmeniRegeneron has won the first-ever FDA approval for a gene therapy to treat a rare type of inherited hearing loss, and the company plans to offer the treatment for free in the US, though that ...Endpoints · 3mo ago↗ source
- Substance use disorder biotech Tempero to close after earlier 'serious' safety eventTempero Bio, a drug developer that had big ambitions to shake up the treatment of substance use disorders, is winding down operations, Endpoints News has learned. The shutdown comes after a "seriou…